Shareholders Equity or Deficit - Additional Information (Detail) - $ / shares		9 Months Ended
	Feb. 13, 2021	Sep. 30, 2022
Equity [Member] | Athyrium Opportunities II Acquisition LP [Member] | Warrants, Exercise Price $6.84, Expiring on November 2024 [Member]
Schedule Of Capitalization Equity [Line Items]
Warrants outstanding to purchase shares, Number of Shares		348,664
Warrant, exercise price per share		$ 1.73
Warrants outstanding to purchase shares, Expiration dates		2024-11
Irisys [Member]
Schedule Of Capitalization Equity [Line Items]
Number of share issued for acquisition	9,302,718
Issuance of common stock , net of costs , shares		9,302,718
Aspire Capital
Schedule Of Capitalization Equity [Line Items]
Purchase commitment of common stock, Shares		41,172
Aspire Capital | Maximum [Member]
Schedule Of Capitalization Equity [Line Items]
Issuance of common stock , net of costs , shares		6,199,299
Aspire Capital | Minimum [Member]
Schedule Of Capitalization Equity [Line Items]
Issuance of common stock , net of costs , shares		30,000